| Literature DB >> 27772789 |
Matthew Swan1, Nancy Doan2, Robert A Ortega2, Matthew Barrett3, William Nichols4, Laurie Ozelius5, Jeannie Soto-Valencia2, Sarah Boschung2, Andres Deik6, Harini Sarva7, Jose Cabassa8, Brooke Johannes2, Deborah Raymond2, Karen Marder9, Nir Giladi10, Joan Miravite2, William Severt2, Rivka Sachdev2, Vicki Shanker2, Susan Bressman2, Rachel Saunders-Pullman11.
Abstract
Mutations in GBA1 are a well-established risk factor for Parkinson disease (PD). GBA-associated PD (GBA-PD) may have a higher burden of nonmotor symptoms than idiopathic PD (IPD). We sought to characterize the relationship between GBA-PD and neuropsychiatric symptoms. Subjects were screened for common GBA1 mutations. GBA-PD (n=31) and non-carrier (IPD; n=55) scores were compared on the Unified Parkinson Disease Rating Scale (UPDRS), Montreal Cognitive Assessment (MoCA), Beck Depression Inventory (BDI), and the State-Trait Anxiety Index (STAI). In univariate comparisons, GBA-PD had a greater prevalence of depression (33.3%) versus IPD (13.2%) (p<0.05). In regression models controlling for age, sex, disease duration, motor disability, and MoCA score, GBA-PD had an increased odds of depression (OR 3.66, 95% CI 1.13-11.8) (p=0.03). Post-hoc analysis stratified by sex showed that, among men, GBA-PD had a higher burden of trait anxiety and depression than IPD; this finding was sustained in multivariate models. Among women, GBA-PD did not confer greater psychiatric morbidity than IPD. These results suggest that GBA1 mutations confer greater risk of neuropsychiatric morbidity in PD, and that sex may affect this association.Entities:
Keywords: Anxiety; Depression; GBA1; Glucocerebrosidase; Parkinson disease
Mesh:
Substances:
Year: 2016 PMID: 27772789 PMCID: PMC5268078 DOI: 10.1016/j.jns.2016.08.059
Source DB: PubMed Journal: J Neurol Sci ISSN: 0022-510X Impact factor: 3.181